Kefang Lai

机构：First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University · ORCID：0000-0001-7994-7296

发表论文 229 篇 · 总被引 5996 次 · h-index 37

代表论文

• Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China (2024 · JMIR Public Health and Surveillance · 被引 16)
• Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia (2024 · Respiratory Medicine · 被引 14)
• Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor: A Pilot Study on Comparable Efficacy in the Treatment of Gastroesophageal Reflux-Related Cough (2024 · Allergy Asthma and Immunology Research · 被引 12)
• AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations (2024 · British Journal of Pharmacology · 被引 9)
• Profile of cough triggers and their relationship with capsaicin cough sensitivity in chronic cough (2024 · Therapeutic Advances in Respiratory Disease · 被引 7)
• Non-allergic eosinophilic inflammation and airway hyperresponsiveness induced by diesel engine exhaust through activating ILCs (2024 · Ecotoxicology and Environmental Safety · 被引 5)